designed an immuno-positron emission tomography (immunoPET) molecular probe targeting Nectin-4 for preclinical evaluation in tumor-bearing mice, based on the finding that Nectin-4 is highly expressed in several cancers with little expression in normal adult tissue (65). The gene discussed is NECTIN4; the disease is cancer.